JPRN-UMIN000006196招募中未知
evaluation of aloGliptin`s eFficacy and saFety based on Renal function Study - evaluation of aloGliptin`s eFficacy and saFety based on Renal function Study (eGFR Study)
适应症
试验速览
- 阶段
- 未知
- 状态
- 招募中
- 入组人数
- 20,000
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- ot applicable 至 ot applicable（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •Patients meeting one of the following conditions will be excluded: 1) Severe ketosis, diabetic coma or precoma, Type 1 diabetes 2) Severe infectious disease, before or after surgery, and severe trauma 3) Past medical history of hypersensitivity to alogliptin 4) hospitalized patient 5) Pregnant, lactating, and possibly pregnant women and those planning to become pregnant 6) Under treatment with other DPP-4 inhibitors and/or GLP-1 analogues 7) Judged as ineligible by clinical investigators
研究者
相似试验
已完成
不适用
Evaluation of efficacy and safety of Alogliptin in type 2 diabetic patients with chronic kidney diseaseType 2 Diabetic Patients with chronic kidney DiseaseJPRN-UMIN000008133Department of Internal Medicine, Division of Nephrology, Juntendo University Faculty of Medicine50
尚未招募
2 期
The effect of Alogliptin in the prevention of Type 1 Diabetes MellitusC18.452.394.750Type 1 Diabetes mellitusRBR-723bk5pniversidade Federal do Ceará
招募中
不适用
A multicenter trial of alogliptin for the safety and efficacy on glycemic control in Japanese type 2 diabetic patients undergoing hemodialysisType 2 diabetic patients undergoing hemodialysisJPRN-UMIN000006082Tokyo Women's Medical University30
撤回
4 期
Safety and Efficacy of Alogliptin in Indian Participants With Type 2 Diabetes MellitusDiabetes Mellitus, Type 2NCT03042325Takeda
已完成
1 期
Pharmacokinetics, Pharmacodynamics, and Safety of Alogliptin in Children, Adolescents and Adults With Type 2 Diabetes MellitusDiabetes Mellitus, Type 2NCT00957268Takeda46